文献速递消化道肿瘤与早癌消化内镜

遗传性弥漫性胃癌易感个体的内镜监测结局

Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
PubMed 文献 · Gastroenterology · 2019-03-29

该研究评估了CDH1基因致病或可能致病变异携带者接受内镜监测的结局。在20名携带者中,12名检出印戒细胞癌,但内镜下均无可见异常;其中7名无一级亲属胃癌诊断且不符合基于三代家系的CDH1检测标准。家族史和内镜表现似乎并非印戒细胞癌风险的可靠决定因素。

要点

  • 20名CDH1致病或可能致病变异携带者中,12名检出印戒细胞癌。
  • 12例印戒细胞癌中7例无一级亲属胃癌诊断且不符合三代家系CDH1检测标准。

核心结论

  • 超过半数CDH1致病或可能致病变异携带者在内镜和/或胃切除术中有弥漫性胃癌的组织病理学证据。
  • 家族史和内镜表现似乎并非遗传性弥漫性胃癌易感个体发生印戒细胞癌风险的可靠决定因素。

研究设计与样本

  • 研究纳入1998年1月至2018年5月在密歇根大学医学中心癌症遗传学诊所评估的来自13个家族的CDH1胚系致病或可能致病变异个体。
  • 比较有和无弥漫性胃癌家族史个体之间的食管胃十二指肠镜检查、组织病理学分析和手术结局。

主要发现

  • 共鉴定20名CDH1胚系致病或可能致病变异携带者,他们接受了内镜检查和/或胃切除术。
  • 所有携带者内镜下均无可见异常发现。
  • 20名受试者中12名检出印戒细胞癌。
  • 12例癌中除1例为透壁性外,其余均微小且局限于固有层。
  • 12名印戒细胞癌受试者中7名无一级亲属弥漫性胃癌诊断,且不符合基于三代家系建立的CDH1分析标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Pathogenic germline variants in CDH1 are associated with risk for diffuse gastric cancer (DGC) and lobular breast cancer. The reported high incidence of DGC and limited sensitivity of endoscopy in detection have prompted recommendation for total prophylactic gastrectomy for carriers of pathogenic or likely pathogenic (PLP) germline variants of CDH1. Multigene panel tests have identified increasing numbers of carriers of PLP variants in CDH1 who lack a family history of DGC. We evaluated outcomes of endoscopic surveillance for carriers of PLP variants of CDH1 with and without family history of DGC. METHODS: Individuals from 13 families with germline PLP variants of CDH1 were evaluated at the Michigan Medicine Cancer Genetics Clinic from January 1998 through May 2018. Outcomes of esophagogastroduodenoscopy examinations, histopathology analyses, and surgery were compared between individuals with and without a family history of DGC. RESULTS: We identified 20 carriers of germline CDH1 PLP variants; they underwent endoscopic examinations and/or gastrectomy. None had abnormal findings visible during endoscopy. Signet ring cell carcinoma (SRCC) was detected in 12 of 20 subjects. All but 1 of the carcinomas were tiny and confined to the lamina propria, and 1 was transmural. Seven of 12 subjects who had SRCC reported no diagnoses of DGC in first-degree relatives and did not meet established criteria for CDH1 analysis based on a 3-generation family pedigree. CONCLUSIONS: More than half of individuals with germlines variants of CDH1 that are PLP had histopathologic evidence for DGC on endoscopy and/or gastrectomy. Family history of DGC and endoscopic findings therefore do not appear to be reliable determinants of risk of SRCC in individuals with genetic predisposition to DGC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Jacobs MF, Dust H, Koeppe E, et al. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer. Gastroenterology. 2019. PMID: 30935944. doi:10.1053/j.gastro.2019.03.047

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。